Tag:
drug safety
Latest Headlines
Latest Headlines
Boehringer: About 50 deaths in Pradaxa patients
One day after U.K. cost-effectiveness gatekeepers gave a preliminary recommendation for its new blood thinner, Boehringer Ingelheim said about 50 patients using the drug have died since its launch
NEJM study finds no CV risks for ADHD drugs
Some of the cloud hanging over attention deficit hyperactivity disorder drugs has evaporated. A new study published in The New England Journal of Medicine found ADHD drugs didn't increase the risk of
Ranbaxy recalls three drugs for lack of safety warnings
Failure to include updated safety warning information for three drugs has led to Ranbaxy recalls in the U.K. The drugs, which pharmacies have been asked to quarantine, are the antiviral aciclovir,
China assesses illegal drug activities
Six departments within the Chinese government started a nationwide drug safety assessment this week, says the Ministry of Health. Goals include establishing order and curtailing illegal activity as
FDA adds warning to BMS leukemia drug
Bristol-Myers Squibb's ( $BMY ) leukemia treatment Sprycel has a new warning. In a new safety announcement, the FDA said the drug can increase the risk of pulmonary arterial hypertension (PAH). The
Rx-360 launch reinforces benefits of shared audits
The drug quality and authenticity nonprofit Rx-360 has launched its audit sharing program, through which members collect and share details of their findings from suppliers' investigations. Members
NZ officials under fire over Pradaxa side effects
New Zealand drug regulators are in the hot seat after two patients using Boehringer Ingelheim's new blood thinner Pradaxa died and 36 others suffered severe bleeding. NZ's Pharmac added the new
Vioxx securities-fraud case moves ahead
Investors will have their chance to fight Merck on Vioxx. A U.S. judge ruled that the drugmaker must face claims that it soft-pedaled the safety risks of its now-withdrawn painkiller, violating
French minister overhauls pharma regs
The scandal surrounding Servier's Mediator drug in France has spawned a new approach to regulating pharma. Under pressure from an increasingly distrustful public, Health Minister Xavier Bertrand has
Study: Pfizer's Chantix raises heart risks 72%
It's another blow for Pfizer's stop-smoking drug Chantix. A new study found that healthy, middle-aged smokers who use the drug have a higher risk of having a heart attack or developing other serious
